Reporting experiments in homeopathic basic research (REHBaR) - A detailed guideline for authors

Homeopathy

Volumn 98, Issue 4, 2009, Pages 287-298

  Stock Schroer B ^a   Albrecht, H ^a   Betti, L ^b   Endler, P C ^c   Linde, K ^d   Ludtke R ^a   Musial, F ^e   van Wijk, R ^f   Witt, C ^g   Baumgartner, S ^h  

^a Karl und Veronica Carstens Stiftung   (Germany)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c Interuniversity College for Health and Development Graz   (Austria)

^d TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^e UNIVERSITY OF DUISBURG ESSEN   (Germany)

^f International Institute of Biophysics   (Germany)

^g CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^h UNIVERSITY OF BERN   (Switzerland)

Author keywords

Criteria catalogue; Delphi; Fundamental research; Guideline; Publication

Indexed keywords

HOMEOPATHIC AGENT;

ARTICLE; AUTHOR; BASIC RESEARCH; DELPHI STUDY; EXPERIMENT; HOMEOPATHY; HUMAN; MEDICAL LITERATURE; NONHUMAN; PUBLICATION; PUBLISHING;

BIOMEDICAL RESEARCH; DELPHI TECHNIQUE; HOMEOPATHY; HUMANS; PUBLISHING;

EID: 71649109159     PISSN: 14754916     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.homp.2009.09.006     Document Type: Article

References (54)

1. Begg C., Cho M., Eastwood S., et al. Improving the quality of reporting of randomized controlled trials. The CONSORT statement. Jama 276 8 (1996) 637-639
2. Moher D., Schulz K.F., and Altman D.G. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials. Lancet 357 9263 (2001) 1191-1194
3. Moher D., Schulz K.F., and Altman D. The CONSORT Statement: revised recommendations for improving the quality of reports of parallel-group randomized trials 2001. Explore (NY) 1 1 (2005) 40-45
4. Hopewell S., Clarke M., Moher D., et al. CONSORT for reporting randomized controlled trials in journal and conference abstracts: explanation and elaboration. PLoS Med 5 1 (2008) e20
5. Zwarenstein M., Treweek S., Gagnier J.J., et al. Improving the reporting of pragmatic trials: an extension of the CONSORT statement. Bmj 337 (2008) a2390
6. Boutron I., Tubach F., Giraudeau B., and Ravaud P. Methodological differences in clinical trials evaluating nonpharmacological and pharmacological treatments of hip and knee osteoarthritis. Jama 290 8 (2003) 1062-1070
7. Simera I., Moher D., Hoey J., Schulz K.F., and Altman D.G. The EQUATOR Network and reporting guidelines: Helping to achieve high standards in reporting health research studies. Maturitas 63 1 (2009) 4-6
8. Moher D., Cook D.J., Eastwood S., et al. Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses. Lancet 354 9193 (1999) 1896-1900
9. Turpin D.L. CONSORT and QUOROM guidelines for reporting randomized clinical trials and systematic reviews. Am J Orthod Dentofacial Orthop 128 6 (2005) 681-685 (discussion 686)
10. Moher D., Liberati A., Tetzlaff J., and Altman D.G. Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement. J Clin Epidemiol (2009)
11. Vandenbroucke J.P., von Elm E., Altman D.G., et al. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. Ann Intern Med 147 8 (2007) W163-W194
12. Little J., Higgins J.P., Ioannidis J.P., et al. STrengthening the REporting of Genetic Association Studies (STREGA): an extension of the STROBE statement. PLoS Med 6 2 (2009) e22
13. MacPherson H., White A., Cummings M., et al. Standards for reporting interventions in controlled trials of acupuncture: the STRICTA recommendations. Complement Ther Med 9 4 (2001) 246-249
14. Davidoff F., Batalden P., Stevens D., Ogrinc G., and Mooney S.E. Publication guidelines for quality improvement studies in health care: evolution of the SQUIRE project. Bmj (2009) 338 a3152
15. Bossuyt P.M., Reitsma J.B., Bruns D.E., et al. Toward complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. Acad Radiol 10 6 (2003) 664-669
16. Dean M.E., Coulter M.K., Fisher P., Jobst K.A., and Walach H. Reporting data on homeopathic treatments (RedHot): a supplement to CONSORT. J Altern Complement Med 13 1 (2007) 19-23
17. Van Wijk R., and Albrecht H. Classification of systems and methods used in biological basic research on homeopathy. Homeopathy 96 4 (2007) 247-251
18. Schulte J. About Quality and standards in Ultra High Dilution Research and Research on Homeopathy. In: Endler P.C.S. (Ed). Ultra High Dilution - Physiology and Physics (1994), Kluwer Academic Publishers, Dordrecht 171-176
19. Linde K., Melchart D., Jonas W.B., and Hornung J. Ways to enhance the quality and acceptance of clinical and laboratory studies in homeopathy. Brit Hom J 83 1 (1994) 3-7
20. Baumgartner S., Heusser P., and Thurneysen A. Methodological Standards and Problems in Preclinical Homoeopathic Potency Research. Forsch Komplementarmed 5 1 (1998) 27-32
21. Linde K., Jonas W.B., Melchart D., et al. Critical review and meta-analysis of serial agitated dilutions in experimental toxicology. Hum Exp Toxicol 13 7 (1994) 481-492
22. Becker-Witt C., Weisshuhn T.E., Ludtke R., and Willich S.N. Quality assessment of physical research in homeopathy. J Altern Complement Med 9 1 (2003) 113-132
23. Hornung J., and Linde K. Guidelines for the Exact Description of the Preparation and Mode of Application of Serial Dilutions and Potencies in Publications on Ultra Low Dose Effects and Homeopathic Research - a proposal-. The Berlin Journal on Research in Homeopathy 1 2 (1991) 121-123
24. Linstone H., and Turoff M. The Delphi Method: Techniques and Applications (2002). http://www.is.njit.edu/pubs/delphibook/
25. Verhagen A.P., de Vet H.C., de Bie R.A., et al. The Delphi list: a criteria list for quality assessment of randomized clinical trials for conducting systematic reviews developed by Delphi consensus. J Clin Epidemiol 51 12 (1998) 1235-1241
26. Flower A., Lewith G.T., and Little P. Seeking an oracle: using the Delphi process to develop practice guidelines for the treatment of endometriosis with Chinese herbal medicine. J Altern Complement Med 13 9 (2007) 969-976
27. Stock-Schröer B., Albrecht H., Betti L., et al. Reporting Experiments in Homeopathic Basic Research (REHBaR) - Description of the Checklist Development. eCAM (2009) (submitted)
28. Cesar B., Abud A.P., de Oliveira C.C., et al. Activation of mononuclear bone marrow cells treated in vitro with a complex homeopathic medication. Micron 39 4 (2008) 461-470
29. Baumgartner S., Thurneysen A., and Heusser P. Growth stimulation of dwarf peas (Pisum sativum L.) through homeopathic potencies of plant growth substances. Forsch Komplementarmed Klass Naturheilkd 11 5 (2004) 281-292
30. Velkers F.C., te Loo A.J., Madin F., and van Eck J.H. Isopathic and pluralist homeopathic treatment of commercial broilers with experimentally induced colibacillosis. Res Vet Science 78 1 (2005) 77-83
31. Nani D., Brizzi M., Lazzarato L., and Betti L. The role of variability in evaluating ultra high dilution effects: considerations based on plant model experiments. Forsch Komplement Med (2006) 14 5 (2007) 301-305
32. Brack A., Strube J., Stolz P., and Decker H. Effects of ultrahigh dilutions of 3,5-dichlorophenol on the luminescence of the bacterium Vibrio fischeri. Biochim Biophys Acta 1621 3 (2003) 253-260
33. Chirumbolo S., Brizzi M., Ortolani R., Vella A., and Bellavite P. Inhibition of CD203c membrane up-regulation in human basophils by high dilutions of histamine: a controlled replication study. Inflamm Res (2009)
34. Walchli C., Baumgartner S., and Bastide M. Effect of low doses and high homeopathic potencies in normal and cancerous human lymphocytes: an in vitro isopathic study. J Altern Complement Med 12 5 (2006) 421-427
35. Weber S., Endler P.C., Welles S.U., et al. The effect of homeopathically prepared thyroxine on highland frogs: influence of electromagnetic fields. Homeopathy 97 1 (2008) 3-9
36. Wiegant F.A., Souren J.E., van Rijn J., and van Wijk R. Stressor-specific Induction of Heat Shock Proteins in Rat Hepatoma Cells. Toxicology 94 (1994) 143-159
37. van Wijk R., Bosman S., and van Wijk E.P. Thermoluminescence in Ultra-High Dilution Research. J Altern Complement Med 12 5 (2006) 437-443
38. Brizzi M., Lazzarato L., Nani D., et al. A biostatistical insight into the As(2)O(3) high dilution effects on the rate and variability of wheat seedling growth. Forsch Komplementarmed Klass Naturheilkd 12 5 (2005) 277-283
39. Elia V.E., Montanino L., Napoli E., Niccoli M., and Nonatelli L. Conductometric studies of the serially diluted and agitated solutions on an anomalous effect that depends on the dilution process. J. Molecular Liquids 135 (2007) 158-165
40. Cazin J.C., Cazin M., Gaborit J.L., et al. A Study of the Effect of Decimal and Centesimal Dilutions of Arsenic on the Retention and Mobilization of Arsenic in the Rat. Human Toxicol 6 (1987) 315-320
41. Witt C.M., Bluth M., Hinderlich S., et al. Does potentized HgCl2 (Mercurius corrosivus) affect the activity of diastase and alpha-amylase?. J Altern Complement Med 12 4 (2006) 359-365
42. Scherr C., Simon M., Spranger J., and Baumgartner S. Effects of potentised substances on growth rate of the water plant Lemna gibba L. Complement Ther Med 17 2 (2009) 63-70
43. Baumgartner S., Shah D., Schaller J., et al. Reproducibility of dwarf pea shoot growth stimulation by homeopathic potencies of gibberellic acid. Complement Ther Med 16 4 (2008) 183-191
44. Witt C., Ludtke R., Weisshuhn T.E., and Willich S.N. High homeopathic potencies are different from potentized solvent when investigated with the REDEM technology. Forsch Komplementarmed Klass Naturheilkd 12 1 (2005) 6-13
45. Wiegant F.A., Souren J.E., and van Wijk R. Stimulation of survival capacity in heat shocked cells by subsequent exposure to minute amounts of chemical stressors; role of similarity in hsp-inducing effects. Hum Exp Toxicol 18 7 (1999) 460-470
46. Folkes A., Urquhart R., and Grunfeld E. Are leading medical journals following their own policies on CONSORT reporting?. Contemp Clin Trials 29 6 (2008) 843-846
47. Brand R.A. Standards of reporting: the CONSORT, QUORUM, and STROBE guidelines. Clin Orthop Relat Res 467 6 (2009) 1393-1394
48. Rios L.P., Odueyungbo A., Moitri M.O., Rahman M.O., and Thabane L. Quality of reporting of randomized controlled trials in general endocrinology literature. J Clin Endocrinol Metab 93 10 (2008) 3810-3816
49. Berwanger O., Ribeiro R.A., Finkelsztejn A., et al. The quality of reporting of trial abstracts is suboptimal: survey of major general medical journals. J Clin Epidemiol 62 4 (2009) 387-392
50. Han C., Kwak K.P., Marks D.M., et al. The impact of the CONSORT statement on reporting of randomized clinical trials in psychiatry. Contemp Clin Trials 30 2 (2009) 116-122
51. Prady S.L., Richmond S.J., Morton V.M., and Macpherson H. A systematic evaluation of the impact of STRICTA and CONSORT recommendations on quality of reporting for acupuncture trials. PLoS ONE 3 2 (2008) e1577
52. Knobloch K., Gohritz A., and Vogt P.M. CONSORT and QUOROM statements revisited: standards of reporting of randomized controlled trials in general surgery. Ann Surg 248 6 (2008) 1106-1107 (discussion 1107-8)
53. Vandenbroucke J.P. STREGA, STROBE, STARD, SQUIRE, MOOSE, PRISMA, GNOSIS, TREND, ORION, COREQ, QUOROM, REMARK. and CONSORT: for whom does the guideline toll?. J Clin Epidemiol 62 6 (2009) 594-596
54. Baumgartner S, The State of Basic Research on Homeopathy, in New Directions in Homeopathy Research - Advice From an Interdisciplinary Conference, In: Albrecht H, Witt C (Eds). KVC-Verlag: Essen, 2009.